ArticleMolecular neurobiology2026
West Nile Virus Exploits miR-155-5p-Mediated Regulation of TRIM32-IκBα Axis to Evade NF-κB-Mediated Innate Immune Responses in Human Microglial Cells.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
West Nile virus (WNV) is a neurotropic virus, having a single-stranded, positive-sense RNA genome belonging to the Flaviviridae family. WNV infection in the brain is associated with many neurological sequelae. Microglia are brain macrophages that respond to pathogenic breaches and eliminate threats. However, WNV is reported to evade cellular challenges and cause infection in the brain. In this study, we explored an underlying strategy by which WNV suppresses inflammation in microglial cells by increasing cellular microRNA-155-5p and dampening nuclear factor of kappa light-chain enhancer of activated B cells (NF-κB) signaling via tripartite motif-containing protein 32 (TRIM32). NF-κB is a crucial transcription factor involved in the production of pro-inflammatory cytokines and mediating cellular response. We observed increased expression of miR-155-5p in WNV-infected human microglial cells. The miR-155-5p-mediated regulation of TRIM32 and downstream NF-κB signaling was validated by miR-155-5p overexpression and knockdown in HMC3 cells. Increased miR-155-5p expression led to decreased TRIM32 expression. The decrease in TRIM32 sequestered the localization of inhibitor of nuclear factor of kappa light chain enhancer of activated B-cells, alpha (IκBα), and reduced its phosphorylation-mediated degradation. Consequently, resulting in decreased phosphorylation of NF-κB and decreased production of inflammatory cytokines. The protein expression patterns of TRIM32, p-IκBα, IκBα, p-NF-κB, NF-κB, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) were assessed by immunoblotting. This study demonstrates that WNV modulates host cellular machinery by dysregulating miR-155-5p, thereby suppressing the host inflammatory response in human microglial cells.
Indexed as
Identifiers
42799954What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.